RR-M03

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NameRR-M03

Drug Alias NameRRM03RRM-03RR-M03

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy > Chimeric antigen receptor Macrophages therapyCell and gene therapy > Cell therapy > Source of cells > Peripheral blood-derivedCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionGlypican-3 modulators

TargetsGlypican-3

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesRock Roc Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRock Roc Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A